ArticleFrontiers in cardiovascular medicine2022

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.

Maximilian Tscharre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.